España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Hepion Pharmaceuticals
HEPA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.1866
0.00960
5.42%
At close: -
$0.1858
-0.00080
-0.43%
After Hours: 7:59 PM EDT
Get Report
Comment
Hepion Pharmaceuticals (HEPA) Forecast
News
Earnings
Hepion Pharmaceuticals (HEPA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Hepion Pharmaceuticals (NASDAQ:HEPA) Stock
Hepion Pharmaceuticals Stock (NASDAQ: HEPA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 28, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, January 24, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, January 23, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, January 22, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
Avi Kapoor
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings
Avi Kapoor
US Stocks Higher; Netflix Profit Beats Estimates
Avi Kapoor
Hepion Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Hepion Pharmaceuticals Announces $9M Public O...
Benzinga Newsdesk
Tuesday, January 21, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Thursday, January 16, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, December 11, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Hepion Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Hepion Pharmaceuticals Announces Termination ...
Benzinga Newsdesk
Monday, December 02, 2024
Hepion Pharmaceuticals Sent An Open Letter To...
Benzinga Newsdesk
Monday, November 11, 2024
Hepion Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Pharma Two B And Hepion Pharmaceuticals Annou...
Benzinga Newsdesk
Friday, October 25, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, October 18, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, September 04, 2024
Hepion Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Pharma Two B and Hepion Pharmaceuticals Files...
Benzinga Newsdesk
Wednesday, August 07, 2024
Hepion Pharmaceuticals Announces Interim CEO ...
Benzinga Newsdesk
Monday, July 22, 2024
Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer
Vandana Singh
Hepion Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Market-Moving News for July 22nd
Benzinga Newsdesk
Pharma Two B To Go Public Through Merger With...
Benzinga Newsdesk
Monday, April 22, 2024
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
Avi Kapoor
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
Vandana Singh
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Gold Falls Sharply; Matterport Shares Spike Higher
Avi Kapoor
Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In March
Avi Kapoor
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Hepion Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Friday, April 19, 2024
Hepion Pharmaceuticals Says Given The Number ...
Benzinga Newsdesk
Hepion Pharmaceuticals Shares Resumed Trading
Benzinga Newsdesk
Trading Halt: Halt status updated at 4:55:00 ...
Benzinga Newsdesk
Hepion Pharmaceuticals Initiates Wind-Down Ac...
Benzinga Newsdesk
Trading Halt: Halted at 4:25:20 p.m. ET - Tra...
Benzinga Newsdesk
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, February 16, 2024
Hepion Pharmaceuticals Announces Immediate Ex...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, February 15, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Tuesday, December 12, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Thursday, December 07, 2023
Brookline Capital Downgrades Hepion Pharmaceu...
Benzinga Newsdesk
Show More